Thomas Secher
Gubra (Denmark)(DK)
Publications by Year
Research Areas
Diabetes Treatment and Management, Chronic Kidney Disease and Diabetes, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy(2014)103 cited
- → A neural cell adhesion molecule–derived fibroblast growth factor receptor agonist, the FGL-peptide, promotes early postnatal sensorimotor development and enhances social memory retention(2006)89 cited
- → Molecular Cloning of a Functional Allatostatin Gut/Brain Receptor and an Allatostatin Preprohormone from the Silkworm Bombyx mori(2001)82 cited
- → Glucagon-Like Peptide-1 Receptor Agonists Increase Pancreatic Mass by Induction of Protein Synthesis(2014)57 cited
- → Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia(2017)48 cited
- → The endogenous preproglucagon system is not essential for gut growth homeostasis in mice(2017)41 cited
- → Differential expression of parvalbumin in neonatal phencyclidine‐treated rats and socially isolated rats(2012)40 cited
- → Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease(2022)32 cited
- → Effect of an NCAM mimetic peptide FGL on impairment in spatial learning and memory after neonatal phencyclidine treatment in rats(2008)29 cited
- → Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease(2021)28 cited